It is still not known whether hematopoiesis reconstituted by autografting with the peripheral blood hematopoietic progenitors (CPCs) after myeloablative high dose radiotherapy and/or chemotherapy is durable and capable of coping with the increased demand imposed by boost radiotherapy, surgery, or infection.

Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors / S. Siena, M. Bregni, M. Di Nicola, F. Ravagani, F. Peccatori, L. Gandola, F. Lombardi, C. Tarella, G. Bonadonna, A. M. Gianni. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 5:10(1994 Dec), pp. 935-41-941.

Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors

S. Siena;C. Tarella;A. M. Gianni
1994

Abstract

It is still not known whether hematopoiesis reconstituted by autografting with the peripheral blood hematopoietic progenitors (CPCs) after myeloablative high dose radiotherapy and/or chemotherapy is durable and capable of coping with the increased demand imposed by boost radiotherapy, surgery, or infection.
Humans; Hematopoietic Cell Growth Factors; Cyclophosphamide; Transplantation, Autologous; Hematopoiesis; Neoplasms; Whole-Body Irradiation; Adult; Hematopoietic Stem Cell Transplantation; Antineoplastic Combined Chemotherapy Protocols; Middle Aged; Time Factors; Female; Male
Settore MED/06 - Oncologia Medica
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/183377
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 66
  • ???jsp.display-item.citation.isi??? 77
social impact